Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )

CELEX: 32017R2065
Document type: REG_IMPL
Sector: Legislation
Date of document: 2017-11-13
In force since: 2017-12-04
Status: In force
ELI: http://data.europa.eu/eli/reg_impl/2017/2065/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1 Confirmation of the conditions of approval

The conditions of approval of the active substance 8-hydroxyquinoline, as set out in Row 18 of Part B of the Annex to Implementing Regulation (EU) No 540/2011, are confirmed.

Article 2 Amendment to the Annex to Implementing Regulation (EU) 2015/408

The name ‘8-hydroxyquinoline’ is inserted between the entry ‘1-methylcyclopropene’ and the entry ‘aclonifen’.

Article 3 Deferred application of Article 2

Implementing Regulation (EU) 2015/408 as modified by Article 2 shall apply for the purposes of Article 50(1) of Regulation (EC) No 1107/2009 only to applications for the authorisation of plant protection products containing 8-hydroxyquinoline submitted after 4 April 2018.

Article 4 Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions